Why Milestone Scientific Inc.’s (MLSS) Stock Is Down 5.79%
As of Wednesday, September 10, Milestone Scientific Inc.’s MLSS share price has dipped by 5.79%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Stock Evaluator: Milestone Scientific Inc. (MLSS)
Milestone Scientific Inc. MLSS
$0.42
0.02
4.73%
September 23, 2026 4:00:00 PM
EST
Volume: 24,771
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
AMEX | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company provides The Wand, a single use disposable handpiece device for dental procedures that require local anesthetic under the CompuDent and STA Single Tooth Anesthesia System names. It also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, the company provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Further, it offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.
Commentary & Analysis
Why Milestone Scientific Inc.’s (MLSS) Stock Is Down 5.80%
As of Monday, August 11, Milestone Scientific Inc.’s MLSS share price has dipped by 5.80%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Why Milestone Scientific Inc.’s (MLSS) Stock Is Up 5.66%
As of Wednesday, July 09, Milestone Scientific Inc.’s MLSS share price has surged by 5.66%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Milestone Scientific Inc.’s (MLSS) Stock Is Down 7.29%
As of Monday, June 30, Milestone Scientific Inc.’s MLSS share price has dipped by 7.29%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Milestone Scientific Inc.’s (MLSS) Stock Is Down 10.52%
As of Monday, June 30, Milestone Scientific Inc.’s MLSS share price has dipped by 10.52%, which has investors questioning if this is right time to buy.Jenna Brashear
Financial Summary
| Share Statistics | MLSS | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $35.2 | $370.3 | 13% |
|
| Shares Out (Mil) | 93.1 | 40.8 | 60% |
|
| Institutional Ownership | 48.7% | 82.8% | 22% |
|
| Float (Mil) | 74.9 | 35.5 | 56% |
|
| Beta | 1.05 | 0.85 | 63% |
|
| Avg Daily Volume (000s) | 94 | 319 | 34% |
|
| Price Change (52-week) |
(23.4%) | 65.8% | 31% |
|
| Growth | MLSS | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 10.8% | 11.8% | 61% |
|
| Net Income (5yr) | 4.8% | (5.7%) | 47% |
|
| EPS (5yr) | 10.2% | 10.2% | 47 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (16.5%) | (15.5%) | 43% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 2 | 2 | |
| Current EPS | ($0.010) | ($0.040) | ($0.035) | |
| Month Ago EPS | ($0.010) | ($0.040) | ($0.035) | |
| # Rev Up | na | 0 | 1 | |
| # Rev Down | na | 1 | 1 | |
| Three Months Ago EPS | ($0.010) | ($0.040) | ($0.035) | |
| Year/Year Chg | (9.1%) | (42.9%) | (71.4%) | |
| Financials | MLSS | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $9 | $119 | 8% |
|
| Net Income (TTM) (Mil) | ($4) | ($9) | 34% |
|
| EPS (TTM) | ($0.049) | ($0.400) | 37% |
|
| Operating Cash Flow (TTM) (Mil) | ($1) | ($3) | 31% |
|
| Net Cash Flow (TTM) (Mil) | $1 | $1 | 45% |
|
| Long-Term Debt (Q1) (Mil) | $1 | $23 | 15% |
|
| Enterprise Value (Q1) (Mil) | $42 | $376 | 15% |
|
| Valuation | MLSS | Industry Median |
Percentile (All Stocks) |
|
| P/B | 9.93 | 2.83 | 90% |
|
| P/E | na | 25.9 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.5 | na |
|
| Ratios | MLSS | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 70.2% | 58.5% | 81% |
|
| Net Margin | (44.0%) | (6.9%) | 12% |
|
| ROA | (50.5%) | (12.3%) | 11% |
|
| ROE | (121.7%) | (11.1%) | 8% |
|
| Liabilities to Assets | 58.4% | 46.6% | 52% |
|
| F-Score | 4 | 4 | 33% |
|
Milestone Scientific Inc. did not pass any screens on 9/22/2026.
